Systemic rheumatic diseases in the ICU

Ítems similars

• The use of recombinant factor VIIa as a haemostatic agent in ICU patients
  per: Vernikos, P, et al.
  Publicat: (2004)
• Trends of resistance of Gram-negative bacteria in the ICU during a 3-year period
  per: Skiada, A, et al.
  Publicat: (2008)
• 0391. Comparison of the histopathologic effects on the lungs of two external chest compression devices (lucas versus autopulse) in a swine model of ventricular fibrillation
  per: Pantazopoulos, C, et al.
  Publicat: (2014)
• 1036. Comparison of the hemodynamic parameters of two external chest compression devices (LUCAS versus AUTOPULSE) in a swine model of ventricular fibrillation
  per: Pantazopoulos, C, et al.
  Publicat: (2014)
• Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
  per: Pavleas, J, et al.
  Publicat: (2006)